You are using an outdated browser. Please upgrade your browser to improve your experience.

Tbio
LY6H
Lymphocyte antigen 6H

Protein Summary
Description
Believed to act as a modulator of nicotinic acetylcholine receptors (nAChRs) activity. In vitro inhibits alpha-3:beta-4-containing nAChRs maximum response. May play a role in the intracellular trafficking of alpha-7-containing nAChRs and may inhibit their expression at the cell surface. Seems to inhibit alpha-7/CHRNA7 signaling in hippocampal neurons.
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000342752
  • ENSP00000342711
  • ENSG00000176956
  • ENST00000414417
  • ENSP00000399485
  • ENST00000430474
  • ENSP00000409899
  • ENST00000610554
  • ENSP00000478470
  • ENSG00000274488
  • ENST00000615409
  • ENSP00000480084
  • ENST00000615434
  • ENSP00000482094
  • ENST00000631670
  • ENSP00000487965

Symbol
  • NMLY6
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
gene perturbation
0.86
PubMedID
0.61
cell line
0.53
tissue sample
0.52
disease perturbation
0.43


Protein Classes
No PANTHER Classes or DTO Classes found
IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 11.74   (req: < 5)
Gene RIFs: 2   (req: <= 3)
Antibodies: 64   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 11.74   (req: >= 5)
Gene RIFs: 2   (req: > 3)
Antibodies: 64   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 5
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0